Paradigm Biopharmaceuticals Ltd
F:P86
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Paradigm Biopharmaceuticals Ltd
F:P86
|
AU |
|
A
|
Amedisys Inc
F:ADY
|
US |
|
B
|
Bausch Health Companies Inc
F:BVF
|
CA |
|
F
|
Funko Inc
F:FU2
|
US |
|
Arbe Robotics Ltd
NASDAQ:ARBE
|
IL |
|
AIC Mines Ltd
ASX:A1M
|
AU |
|
I
|
Infratil Ltd
ASX:IFT
|
NZ |
|
Pharming Group NV
F:PHGN
|
NL |
|
N
|
Nippon Telegraph and Telephone Corp
XBER:NTT
|
JP |
|
Ebix Inc
OTC:EBIXQ
|
US |
|
A
|
Asahi Group Holdings Ltd
XMUN:ABW
|
JP |
|
Endesa SA
OTC:ELEZY
|
ES |
|
Straumann Holding AG
F:QS5
|
CH |
|
H
|
Honda Motor Co Ltd
SWB:HDMA
|
JP |
|
V
|
Viasat Inc
DUS:VS1
|
US |
|
E
|
Ence Energia y Celulosa SA
SWB:ENCA
|
ES |
|
R
|
Ren Redes Energeticas Nacionais SGPS SA
ELI:RENE
|
PT |
Wall St Price Targets
P86 Price Targets Summary
Paradigm Biopharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for P86 is 0.247 EUR with a low forecast of 0.244 EUR and a high forecast of 0.254 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is P86's stock price target?
Price Target
0.247
EUR
According to Wall Street analysts, the average 1-year price target for P86 is 0.247 EUR with a low forecast of 0.244 EUR and a high forecast of 0.254 EUR.
What is the Revenue forecast for Paradigm Biopharmaceuticals Ltd?
Projected CAGR
179%
Over the last 10 years, the compound annual growth rate for Revenue has been 99%. The projected CAGR for the next 3 years is 179%.
What is the Gross Profit forecast for Paradigm Biopharmaceuticals Ltd?
Projected CAGR
181%
The compound annual growth rate for Gross Profit over the next 3 years is 181%.
